Opioid Use For Pain Management Coursework Example

Resolution Matrix for the Use of Opioids
Name
Institutional Affiliation

Resolution Matrix for the Use of Opioids
The use of opioids as pain relievers has come under sharp criticism from various sectors. Myths regarding the application of opioids as pain relievers have also played instrumental roles in raising genuine concerns regarding addiction and overdependence on the drug. As a result, there have been numerous calls emphasizing on the need to develop alternative methods that would help eliminate the need for using opioids given the fact that they are creating adverse effects on the well-being of patients. The implementation of the resolutions ought to assess the anticipated benefits and challenges of their implementation with regards to the health of the patient. The impact of each resolution to the health of the patient and the society must also be assessed prior to their implementation.
Matrix chart for the identification of various resolutions as strategies
Element Implement genomic variations of the drug Development of alternative formulations for opioids Creating awareness through evidence-based research
Cost of each resolution Creating a genomic variation for opioids is undoubtedly a costly affair. Research will have to be conducted to help come up with the respective genomic variations for opioids. Besides, relevant investments for infrastructure must be conducted to ensure that upon the development of the genomic drug, manufacturers have the respective strain of the opioids that should be used for the management of pain amongst patients.

The report by Agarwal Udoji and Trescot, (2017) alludes that the development of feasible opioid solutions would cost 80% less of the current costs of the production of opioids variations, which is estimated at $880000. Thus, a reduction in the production cost of the drug, while at the same time ensure that the health of the patient is guaranteed is a win-win situation for the medical fraternity and the patient The development of alternative formulations for opioids also provides a feasible solution to ensure that patients suffering from pain receive reprieve. Unfortunately, efforts to develop an alternative powerful drug such as that with similar formulations as opioids would arguably be extensive. It would demand new research that would test on the viability of the drug prior to its launch (National Institute of Health. (NIH), 2018). Estimations of the research alone could cost the medical world at least $ 1 Million dollars (Drewes et al. 2013). Then, the development of the drug would also require the setup of relevant infrastructure and ensure the availability of resources to facilitate the production process Creating awareness of the impacts of opioids regarding its addictive properties is the most affordable. The government will invest in relevant campaigns, advertisements, and programs that aim at discouraging the use of opioids as pain managers. Unfortunately, the proposal indicated that the methodology must be combined with another method to help realize efficacy. Suggesting the option implies that stakeholders must also prepare to incur other costs related to the development and purchase of pain management drugs.
Financial implications of each resolution The financial implication of developing genomic variations is manageable. The money used in the research and the development of alternative pain management drugs would be sufficient to help eliminate incidences of addiction yet ensure that patients are relieved from pain. The cost of delivery of care is also expected to reduce given the fact that its production is 80% less than the value of producing opioids The development of an alternative pain reliever may require the intervention of both the ministry of health and the finance sector to ensure adequate allocation of funds for treatment. The cost of delivery of care may go high, as the medical team would still be unsure of the margins to set based on the effectiveness of the drug Creating awareness has positive implications on finances, as families would be relieved of the burden of dealing with the addiction of opioids. Subsequently, the campaigns would not have a direct impact on the production of drugs and hence the costs associated with the process
Economic The economic implication of the development of opioids implies that the society would save more persons yet ensure the effective administration of pain relievers. There would be effective management of addiction thus minimize other costs associated with dealing with the addiction of the drug, which also renders the society non-productive The creation of an alternative drug would have positive impacts on the economy. Exports can be realized out of the process, as the pharmaceutical industry would introduce an alternative for pain management. Besides, the productivity of patients post the recovery period would be guaranteed unlike when they are dependent on opioids for pain management The economic implications of creating awareness can only be realized if the campaigns are effective. That implies that the costs associated with the administration of alternative pain management drugs would have also gone low, thus reducing the burden of managing opioid addiction
Resources The resources required for the process include: qualified personnel, financial incentive and relevant infrastructure The resources required for the process include: qualified personnel, financial incentive and relevant drug production infrastructure Qualified personnel would provide the relevant support to ensure that alternative drug formulations are supported instead of using opioids
Quality of care The use of genomic variations will eliminate incidences of addiction yet ensure reprieve for the patient. Issuance of new drug options is a feasible way to ascertain improved care outcomes and thus the delivery of quality care (Kapur, Lala & Shaw, 2014) Creating awareness does not have an impact on the quality of care. However, it implies that the alternatives used would be assessed to determine the quality care
Patient outcomes
An alternative treatment that eliminates the addiction of opioids is a better alternative for pain management (Kapur, Lala & Shaw, 2014). An alternative treatment that eliminates the addiction of opioids is a better alternative for pain management. Crating awareness does not provide the guarantee that the patient would be healed. Rather, it ensures that opioids are eliminated from treatment plans to eliminate incidences of addiction

References
Agarwal, D., Udoji, M. A., & Trescot, A. (2017). Genetic testing for opioid pain management: A primer. Pain and therapy, 6(1), 93-105.
Drewes, A. M., Jensen, R. D., Nielsen, L. M., Droney, J., Christrup, L. L., Arendt‐Nielsen, L., … & Dahan, A. (2013). Differences between opioids: pharmacological, experimental, clinical and economical perspectives. British journal of clinical pharmacology, 75(1), 60-78.
Kapur, B. M., Lala, P. K., & Shaw, J. L. (2014). Pharmacogenetics of chronic pain management. Clinical biochemistry, 47(13-14), 1169-1187.
National Institute of Health. (2018). NIH Initiative to Help End the Opioid Crisis. Retrieved from https://www.nih.gov/research-training/medical-research-initiatives/opioid-crisis